The study identified six clinical manifestations, namely: post-exertion malaise (PEM) (87%), fatigue (85%), brain fog (64%), dizziness (62%), GI (59%), and palpitations (57%), as the most prominent PASC symptoms
How can I keep the weight off once I stop GLP-1s
Q: What is the hormone GLP-1
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist that mimics GLP-1 actions
However, several studies point to a potential nephroprotective role of this pharmacological group in other populations, induced by different factors: improvement of hyperglycemia, overweight and insulin resistance, systemic and glomerular hypertension, dyslipidemia, sodium retention, inflammation and renal hypoxia.15,16 In our series, renal function remained stable, in line with that reported in other series of KT recipients.810 Therefore, our data appear to confirm the notion that, with appropriate monitoring, GLP-1 RAs are safe drugs regarding graft function
These cells can become cholesterol-filled foam cells, an important feature of developing atherosclerotic plaque